Kevin Bowrin

Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study

Craig I Coleman, Matthias Antz, Kevin Bowrin et al. · Current Medical Research and Opinion · 2016 · 101 citations

Medicine, Cardiology, Pharmacotherapy +17

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation

Craig I Coleman, J Brière, Laurent Fauchier et al. · Journal of Market Access & Health Policy · 2019 · 38 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +15

Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective

Ernest Choy, Selwyn Richards, Kevin Bowrin et al. · Current Medical Research and Opinion · 2010 · 22 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with vitamin K antagonists in patients with nonvalvular atrial fibrillation: a systematic literature review

J Brière, Kevin Bowrin, Craig I Coleman et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2018 · 22 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

The cost-effectiveness of an extended course (12+12 weeks) of varenicline plus brief counselling compared with other reimbursed smoking cessation interventions in Belgium, from a public payer perspective.

C Knight, Sophie Marbaix, Lieven Annemans et al. · PubMed · 2013 · 11 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17